{"denoms":[{"counts":[{"groupId":"BG000","value":"30"}],"units":"Participants"}],"groups":[{"description":"Taken orally once a day (in the AM) on days 1 through 21 of a 28-day cycle for a maximum of 6 cycles.\n\nClofarabine: Taken orally once a day (in the AM) on days 1 through 21 of a 28-day cycle for a maximum of 6 cycles.","id":"BG000","title":"Clofarabine Phase I"}],"measures":[{"classes":[{"categories":[{"measurements":[{"groupId":"BG000","lowerLimit":"47","upperLimit":"88","value":"62"}]}]}],"dispersionType":"FULL_RANGE","paramType":"MEDIAN","title":"Age, Continuous","unitOfMeasure":"years"},{"classes":[{"categories":[{"measurements":[{"groupId":"BG000","value":"15"}],"title":"Female"},{"measurements":[{"groupId":"BG000","value":"15"}],"title":"Male"}]}],"paramType":"COUNT_OF_PARTICIPANTS","title":"Sex: Female, Male","unitOfMeasure":"Participants"},{"classes":[{"categories":[{"measurements":[{"groupId":"BG000","value":"30"}]}],"title":"United States"}],"paramType":"NUMBER","title":"Region of Enrollment","unitOfMeasure":"participants"},{"classes":[{"categories":[{"measurements":[{"groupId":"BG000","lowerLimit":"1","upperLimit":"7","value":"1"}]}]}],"dispersionType":"FULL_RANGE","paramType":"MEDIAN","title":"Number of prior regimens","unitOfMeasure":"number of prior regimens"},{"classes":[{"categories":[{"measurements":[{"groupId":"BG000","value":"7"}],"title":"follicular lymphoma (FL)"},{"measurements":[{"groupId":"BG000","value":"6"}],"title":"small lymphocytic lymphoma (SLL)"},{"measurements":[{"groupId":"BG000","value":"3"}],"title":"diffuse large B-cell lymphoma (DLBCL)"},{"measurements":[{"groupId":"BG000","value":"7"}],"title":"marginal zone lymphoma (MZL)"},{"measurements":[{"groupId":"BG000","value":"6"}],"title":"mantle cell lymphoma (MCL)"},{"measurements":[{"groupId":"BG000","value":"0"}],"title":"T-cell lymphoma (TCL)"},{"measurements":[{"groupId":"BG000","value":"1"}],"title":"lymphoplasmacytic lymphoma (LPL)"}]}],"paramType":"COUNT_OF_PARTICIPANTS","title":"Histologies","unitOfMeasure":"Participants"}],"populationDescription":"Phase I participants"}